{
    "nct_id": "NCT05341947",
    "official_title": "A Phase I Trial of Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma",
    "inclusion_criteria": "* Recurrent glioblastoma\n* HLA-A1 and HLA-A2 positive\n* Complete resection of tumor\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Clinically significant pulmonary, cardiac or other systemic disease\n* Presence of an acute infection requiring active treatment with antibiotics/antivirals; prophylactic administration is allowed.\n* Known human immunodeficiency virus positivity or acquired immunodeficiency syndrome related illness or other serious medical condition.\n* Known history of Hepatitis B or Hepatitis C\n* Allergy to Dimethyl sulfoxide (DMSO)\n* Allergy to gentamicin",
    "miscellaneous_criteria": ""
}